| CAS ID: | 191732-72-6 |
| Molecular Formula: | C13H13N3O3 |
| Molecular Weight: | 259.3 g/mol |
| Monoisotopic Mass: | 259.0957 g/mol |
| Class: | Small Molecule |
| Natural Product: | No |
| Other Names: | REVLIMID | CDC-501 | CC-5013 | LENALIDOMIDE |
| Analysis: | Drug repositioning mechanism analysis |
Reference Record 1
| PubMed ID | 26088933 | Target ID | |
| Uniprot ID | Name | ||
| Model | human | Fibrosis Disease | Bone marrow fibrosis |
| Process I | |||
| Process II | |||
| Process III | |||
| Mechanism | |||
Trial Record 1
| ClinicalTrial ID | NCT02705638 | Disease | Retroperitoneal fibrosis |
| Phase | Phase 1 | Status | Active, not recruiting |
| First Received | March 10, 2016 | Last Verified | February 12, 2019 |
| Sponsor | Mayo Clinic | ||